Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nanotechnological applications to open up new opportunities to treat diseases in 15 years time

19.09.2006
On Friday 15th, the Spanish Nanomedicine Platform (Nanomed Spain) and the European Technology Platform on Nanomedicine presented reports on the current status of nanomedicine in Spain and the strategic lines of action at European level to promote R+D in this field.

Both organizations coincide in emphasising that nanotechnology may have direct applications in medicine by contributing to improvements in health and quality of life, and moreover at a reduced cost. The Spanish report, in addition, estimates that the advances currently being developed in this field will reach the health system in the next fifteen years.

However, in its report entitled “Strategic vision of nanomedicine in Spain”, the Nanomed Spain Platform states that nanomedicine is currently in embryonary stage and that it is necessary to strengthen an industrial sector that allows scientific and technological advances to be transferred to specific applications in the health system.

Josep Samitier, coordinator of the Nanomed Spain Platform, affirmed that “Spain can play a relevant role in the development of this field because it has cutting-edge research centres, industrial and pharmaceutical sectors that are interested in using new technologies, as well as a health care system based on a network of hospitals that performs international basic and clinical research”.

According to the report by the Nanomed Spain Platform, as an innovative sector, nanomedicine requires larges investments, will be developed towards applications which yield a significant benefit and in addition, will respond to the health care issues which until now have not been addressed because of scientific or financial limitations.

In this regard, in its Strategic Research Agenda (SRA), the European Technology Platform on Nanomedicine has defined the priority lines of development in European R+D in nanomedicine for the coming years. These lines focus on cardiovascular diseases, cancer, muscular-skeletal disorders, neurodegenerative diseases, diabetes and bacterial and viral infectious diseases, such as AIDS. According to this report, these priorities have been established because they produce a considerable decrease in the quality of life, have a high social and economic cost and because nanotechnology can contribute to the healing process.

These two reports coincide in three application lines for nanomedicine: diagnosis, drug delivery and regenerative medicine. In the first field, devices or sensors will be developed that allow a faster and more reliable diagnosis in early stages of the disease and at a low cost in most cases, for example, cancer.

Regarding drug delivery, nanotechnological advances will allow the effective introduction of the so-called “personalized therapy”, such as administration of a small dose of a drug to obtain maximum effect; the reduction of secondary effects by means of drugs that act only on the therapeutic target; or the development of new more effective administration routes which are comfortable for the patient, such as the nasal administration of insulin. In this regard, for cancer patients, drug delivery systems will be directed exclusively to cancerous cells, thereby avoiding the secondary effects of present chemotherapy protocols.

Another field for the application of nanotechnology is regenerative medicine, in which it will allow the substitution of cells or tissues that do not work for equivalent ones that do, for example in the case of patients with degenerative diseases; as well as tissue regeneration. In the case of cardiovascular diseases, nanotechnology offers the opportunity to develop intelligent nanobiomaterials for the regeneration of tissues, for example in the case of myocardial infarction.

Susana Herráiz | alfa
Further information:
http://www.pcb.ub.es/homePCB/live/en/o190.asp?nid=1336

More articles from Life Sciences:

nachricht Rainbow colors reveal cell history: Uncovering β-cell heterogeneity
22.09.2017 | DFG-Forschungszentrum für Regenerative Therapien TU Dresden

nachricht The pyrenoid is a carbon-fixing liquid droplet
22.09.2017 | Max-Planck-Institut für Biochemie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>